Do Yeon Kim, Jong Seok Park, Hai-Dan Yuan, Sung Hyun Chung
언어
영어(ENG)
URL
https://www.earticle.net/Article/A103097
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Fermented ginseng (FG) is an ethanol extract of ginseng radix processed with β-galactosidase. It was hypothesizedthat FG may exert anti-hyperlipidemic and anti-diabetic activities through modulating AMP-activated protein kinase (AMPK)in HepG2 human hepatoma cells. In this study, we showed that AMPK phosphorylation was stimulated by FG. These effectswere abolished by pretreatment with an AMPK inhibitor, compound C. In addition, FG regulated the expression of genesassociated with lipogenesis and lipolysis, thus causing suppression of hepatic triglyceride accumulation. In vivo study usingdb/db mice, FG reduced fasting plasma glucose, HbAlc, and insulin resistance index, when compared to diabetic control. FGalso increased the phospho-AMPK and glucose transporter 4 (GLUT4) expressions in liver and skeletal muscle, respectively.In liver, expressions of lipogenic gene were decreased whereas expressions of lipolytic genes were induced, when compared todiabetic control. Taken together, we may suggest that FG ameliorates hyperglycemia and hyperlipidemia through activation ofAMPK and could be developed as a health functional food or therapeutic agent for type 2 diabetic patients.
목차
Abstract Introduction Materials and Methods Results and Discussion References
Do Yeon Kim [ Department of Life and Nanopharmaceutical and Department of Pharmaceutical Science, Kyung Hee University, Seoul 130-701, Korea ]
Jong Seok Park [ Department of Life and Nanopharmaceutical and Department of Pharmaceutical Science, Kyung Hee University, Seoul 130-701, Korea ]
Hai-Dan Yuan [ Department of Life and Nanopharmaceutical and Department of Pharmaceutical Science, Kyung Hee University, Seoul 130-701, Korea ]
Sung Hyun Chung [ Department of Life and Nanopharmaceutical and Department of Pharmaceutical Science, Kyung Hee University, Seoul 130-701, Korea ]
Corresponding author